Paediatric consumer health is expected to see higher current value growth than in any other year of the review period in 2020. Panic-buying due to the fear of lockdown and shortages early in the COVID-19 pandemic led parents to hoard paediatric consumer health products in the first half of the year, particularly paediatric vitamins, nappy (diaper) rash treatments and cough/cold remedies.
Online healthcare start-up applications have become a preferred resource for parents seeking help and advice during emergencies. Parents tend to panic more when something harms or has the potential to harm their children than they do when something happens to themselves.
Local brands are expected to continue to dominate paediatric consumer health in value terms in 2020. Soho Industri Pharmasi is set to extend its lead, and remain the only player to hold a double-digit value share.
Despite the strong increase in the current value growth rate expected in 2020, paediatric consumer health is not expected to see much of a slowdown in its growth rate in 2021, with only a very gradual slowdown in the growth rates expected over the course of the forecast period. Indeed, the CAGR in the forecast period overall is expected to be higher than that seen in the review period.
The growth rate of paediatric vitamins and dietary supplements is expected to remain high over the forecast period, as protecting children’s immune systems becomes a permanent habit as parents will become more cautious with their children’s health. Paediatric vitamins and dietary supplements posted the highest growth within paediatric consumer health in the review period, and this is expected to continue in the forecast period, although due to the lasting impact of COVID-19, growth is expected to be stronger than ever, despite already being by far the largest category within paediatric consumer health.
Paediatric cough/cold remedies is expected to remain the second-biggest category within paediatric consumer health in the forecast period. It is forecast to maintain a similar double-digit current value CAGR to that seen in the review period.
Files are delivered directly into your account soon after payment is received and any tax is certification is verified (where applicable).
Understand the latest market trends and future growth opportunities for the Paediatric consumer health industry in Indonesia with research from Euromonitor International's team of in-country analysts – experts by industry and geographic specialisation.
Key trends are clearly and succinctly summarised alongside the most current research data available. Understand and assess competitive threats and plan corporate strategy with our qualitative analysis, insight and confident growth projections.
If you're in the Paediatric consumer health industry in Indonesia, our research will help you to make informed, intelligent decisions; to recognise and profit from opportunity, or to offer resilience amidst market uncertainty.
This report originates from Passport, our Paediatric consumer health research and analysis database.
If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extract FREE! Home Page